Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

NYVEPRIA

PEGFILGRASTIM-APGF

Standard Dose
6MG/0.6ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NYVEPRIA is listed in Drugs@FDA under application 761111 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PEGFILGRASTIM-APGF Form and strength INJECTABLE;INJECTION - 6MG/0.6ML Sponsor HOSPIRA INC Submission history Latest submission status date: 2021-04-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview NYVEPRIA is listed in Drugs@FDA under application 761111 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient PEGFILGRASTIM-APGF Form and strength INJECTABLE;INJECTION - 6MG/0.6ML Sponsor HOSPIRA INC Submission history Latest submission status date: 2021-04-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
NYVEPRIA (PEGFILGRASTIM-APGF) | Drug Monograph | MedicHelpline